EVP, Head of US Oncology
Disclosures on record
8
Companies involved
1
Stock since the trade +0.4% · S&P 500 +1.8% · to Oct 1Traded 12 days before resultsStock within 2% of its 52-week high, after a 26% rise in the previous month
65K → 64K shares held−2% of their stake
Incyte's Head of U.S. Commercial sold $126K of Incyte shares. Nobody planned it ahead of time.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.
Officer sold ~$1.18M of Incyte
Automatic saleRoutine share withholding; mechanical by default.